tiprankstipranks
Genmab A/S (DE:GE91)
STUTTGART:GE91

Genmab (GE91) Cash flow

2 Followers

Genmab Cash Flow

DE:GE91's free cash flow for Q4 2023 was kr―. For the 2023 fiscal year, DE:GE91's free cash flow was decreased by kr3.41B and operating cash flow was kr―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
kr 2.93Bkr 7.38Bkr 3.91Bkr 2.23Bkr 6.43Bkr 1.33B
Investing Cash Flow
kr -1.96Bkr -1.28Bkr -2.76Bkr -961.00Mkr -2.35Bkr -1.98B
Financing Cash Flow
kr -856.00Mkr -606.00Mkr -789.00Mkr -420.00Mkr 71.00Mkr 3.66B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 20.19Bkr 14.87Bkr 9.89Bkr 8.96Bkr 7.26Bkr 3.55B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---kr 0.00kr 0.00kr 3.87B
Issuance Of Debt
-kr -91.00Mkr -73.00M---
Repayment Of Debt
kr -31.00Mkr -91.00Mkr -73.00Mkr -58.00Mkr -44.00Mkr -31.00M
Free Cash Flow
kr 2.78Bkr 7.00Bkr 3.60Bkr 1.98Bkr 6.13Bkr 1.22B
Domestic Sales
------
Foreign Sales
------
Currency in DKK

Genmab Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis